Archean Chemical Industries Limited has informed the Exchange about Investor Presentation

Archean Chemical reported FY26 total revenue of Rs. 11,080 million, up 3% YoY, but Q4FY26 revenue declined 13% to Rs. 3,063 million. Industrial Salt segment grew 10% to Rs. 7,286 million with 4.25 million tons volumes, while Bromine revenues fell 13% to Rs. 3,084 million due to technical downtime. Standalone EBITDA declined 17% to Rs. 3,080 million due to logistics disruptions (road repairs adding 50-100% distance) and 50% rise in fuel costs. Bromine Derivatives business (Acume Chemicals) is targeting breakeven in FY27 with improved capacity utilization. The company has begun commercial operations at Idealis Mudchemie (Mud Chemicals). Management recommended a final dividend of Rs. 2.50 per share. The semiconductor subsidiary SiCSem executed a Fiscal Support Agreement with India Semiconductor Mission for its SiC manufacturing facility in Bhubaneswar, Odisha.